title: Bismuth(III) 5-sulfosalicylate complexes: structure, solubility and activity against Helicobacter pylori.
abstract: Treatment of 5-sulfosalicylic acid (H(3)Ssal) with BiPh(3) results in the formation of the first dianionic carboxylate-sulfonate bismuth complex, [PhBi(HSsal)H(2)O](infinity) 1a, and its ethanol analogue [PhBi(HSsal)EtOH](infinity) 1b (space group P2(1)/c), while Bi(OAc)(3) gives the mixed monoanionic and dianionic complex, {[Bi(HSsal)(H(2)Ssal)(H(2)O)(3)](2) x 2 H(2)O}(infinity) 2 (space group P1). The three complexes are all polymeric in the solid state as determined by single crystal X-ray diffraction, with extended frameworks constructed from dimeric [Bi(HSsal)](2), 1a and 1b, or from [Bi(HSsal)(H(2)Ssal)](2) units, 2. The heteroleptic bismuth complexes 1a and 2 display remarkable aqueous solubility, 10 and 2.5 mg ml(-1) respectively, resulting in a clear solution of pH 1.5. In contrast, 1b is essentially insoluble in aqueous environments. All three complexes show significant activity against the bacterium Helicobacter pylori of <6.25 microg ml(-1).
authors: School of Chemistry, Monash University, Clayton, Melbourne, Vic. 3800, Australia. phil.andrews@sci.monash.edu.au
authors: Philip C
authors: PC
authors: Andrews
authors: Glen B
authors: GB
authors: Deacon
authors: Richard L
authors: RL
authors: Ferrero
authors: Peter C
authors: PC
authors: Junk
authors: Abdulgader
authors: A
authors: Karrar
authors: Ish
authors: I
authors: Kumar
authors: Jonathan G
authors: JG
authors: MacLellan
mesh_terms: D001729:Bismuth / Q000737:chemistry*; D018360:Crystallography, X-Ray; D016480:Helicobacter pylori / Q000187:drug effects*; D008968:Molecular Conformation; D009942:Organometallic Compounds / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D012459:Salicylates / Q000737:chemistry* / Q000494:pharmacology; D012995:Solubility; D013696:Temperature
chemical_list: D009942:Organometallic Compounds; D012459:Salicylates; D001729:Bismuth